alendronate has been researched along with von Hippel-Lindau Disease in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eshed, V | 1 |
| Dresner, J | 1 |
| Gross, D | 1 |
1 other study available for alendronate and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Osteoporosis and amenorrhea in a young patient with von Hippel-Lindau disease.
Topics: Adult; Alendronate; Amenorrhea; Calcium; Cerebellar Neoplasms; Female; Hemangioblastoma; Humans; Hyp | 2005 |